Lattice Therapeutics, Inc. — Form D

Lattice Therapeutics, Inc. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-14. The offering totals $900K, of which $300K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-06-14
• Form: D
• Accession: 0001933805-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $900K
• Amount sold: $300K
• Remaining: $600K
• Investors: 3
• Date of first sale: 2022-05-26
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-449072

Issuer

• Name: Lattice Therapeutics, Inc.
• CIK: 0001933805
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 4314 13TH PLACE NE, WASHINGTON, DC, 20017
• Phone: 205-837-8664

Officers, directors & promoters (3)

More

• CIK 1933805 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search